Synchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children

References

• McCullers JA, Tuomanen EI. Molecular pathogenesis of pneumococcal pneumonia. Front Biosci: J Virtual Libr 2001; 6:D877-89; PMID:11502489; http://dx.doi.org/10.2741/McCullers
   PubMedGoogle Scholar
• Huber VC, Thomas PG, McCullers JA. A multi-valent vaccine approach that elicits broad immunity within an influenza subtype. Vaccine 2009; 27:1192-200; PMID:19135117; http://dx.doi.org/10.1016/j.vaccine.2008.12.023
   PubMed Web of Science ®Google Scholar
• Perera PY, Derrick SC, Kolibab K, Momoi F, Yamamoto M, Morris SL, Waldmann TA, Perera LP. A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in mice. Vaccine 2009; 27:2121-7; PMID:19356615; http://dx.doi.org/10.1016/j.vaccine.2009.01.132
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA 2007; 298:1772-8; PMID:17940232; http://dx.doi.org/10.1001/jama.298.15.1772
   PubMed Web of Science ®Google Scholar
• Francis JP, Richmond PC, Pomat WS, Michael A, Keno H, Phuanukoonnon S, Nelson JB, Whinnen M, Heinrich T, Smith WA, et al. Maternal antibodies to pneumolysin but not to pneumococcal surface protein A delay early pneumococcal carriage in high-risk Papua New Guinean infants. Clin Vaccine Immunol 2009; 16:1633-8; PMID:19776196; http://dx.doi.org/10.1128/CVI.00247-09
   PubMed Web of Science ®Google Scholar
• Schachern PA, Tsuprun V, Goetz S, Cureoglu S, Juhn SK, Briles DE, Paparella MM, Ferrieri P. Viability and virulence of pneumolysin, pneumococcal surface protein A, and pneumolysin/pneumococcal surface protein A mutants in the ear. JAMA Otolaryngol Head Neck Surg 2013; 139:937-43; PMID:24051749; http://dx.doi.org/10.1001/jamaoto.2013.4104
   PubMedGoogle Scholar
• Feldman C, Anderson R. Review: current and new generation pneumococcal vaccines. J Infect 2014; 69:309-25; PMID:24968238; http://dx.doi.org/10.1016/j.jinf.2014.06.006
   PubMed Web of Science ®Google Scholar
• Rapola S, Jantti V, Haikala R, Syrjanen R, Carlone GM, Sampson JS, Briles DE, Paton JC, Takala AK, Kilpi TM, et al. Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media. J Infect Dis 2000; 182:1146-52; PMID:10979911; http://dx.doi.org/10.1086/315822
   PubMed Web of Science ®Google Scholar
• Lebon A, Verkaik NJ, Labout JA, de Vogel CP, Hooijkaas H, Verbrugh HA, van Wamel WJ, Jaddoe VW, Hofman A, Hermans PW, et al. Natural antibodies against several pneumococcal virulence proteins in children during the pre-pneumococcal-vaccine era: the generation R study. Infect Immun 2011; 79:1680-7; PMID:21282409; http://dx.doi.org/10.1128/IAI.01379-10
   PubMed Web of Science ®Google Scholar
• Rapola S, Kilpi T, Lahdenkari M, Takala AK, Makela PH, Kayhty H. Do antibodies to pneumococcal surface adhesin a prevent pneumococcal involvement in acute otitis media? J Infect Dis 2001; 184:577-81; PMID:11494164; http://dx.doi.org/10.1086/322763
   PubMedGoogle Scholar
• Simell B, Ahokas P, Lahdenkari M, Poolman J, Henckaerts I, Kilpi TM, Käyhty H. Pneumococcal carriage and acute otitis media induce serum antibodies to pneumococcal surface proteins CbpA and PhtD in children. Vaccine 2009; 27:4615-21; PMID:19524618; http://dx.doi.org/10.1016/j.vaccine.2009.05.071
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Kaur R, Casey JR, Xu Q, Almudevar A, Ochs M. Antibody response to Streptococcus pneumoniae proteins PhtD, LytB, PcpA, PhtE and Ply after nasopharyngeal colonization and acute otitis media in children. Hum Vaccines Immunother 2012; 8:799-805; PMID:22495112; http://dx.doi.org/10.4161/hv.19820
   PubMed Web of Science ®Google Scholar
• Kaur R, Casey JR, Pichichero ME. Serum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone children. Pediat Infect Dis J 2011; 30:645-50; PMID:21487325; http://dx.doi.org/10.1097/INF.0b013e31821c2d8b
   PubMed Web of Science ®Google Scholar
• Sharma SK, Casey JR, Pichichero ME. Reduced memory CD4+ T-cell generation in the circulation of young children may contribute to the otitis-prone condition. J Infect Dis 2011; 204:645-53; PMID:21791667; http://dx.doi.org/10.1093/infdis/jir340
   PubMed Web of Science ®Google Scholar
• Sharma SK, Casey JR, Pichichero ME. Reduced serum IgG responses to pneumococcal antigens in otitis-prone children may be due to poor memory B-cell generation. J Infect Dis 2012; 205:1225-9; PMID:22383675; http://dx.doi.org/10.1093/infdis/jis179
   PubMed Web of Science ®Google Scholar
• Khan MN, Sharma SK, Filkins LM, Pichichero ME. PcpA of Streptococcus pneumoniae mediates adherence to nasopharyngeal and lung epithelial cells and elicits functional antibodies in humans. Microbes Infect/Institut Pasteur 2012; 14:1102-10; PMID:22796387; http://dx.doi.org/10.1016/j.micinf.2012.06.007
   PubMed Web of Science ®Google Scholar
• Khan MN, Pichichero ME. Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans. Vaccine 2012; 30:2900-7; PMID:22349524; http://dx.doi.org/10.1016/j.vaccine.2012.02.023
   PubMed Web of Science ®Google Scholar
• Sharma SK, Roumanes D, Almudevar A, Mosmann TR, Pichichero ME. CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens. Vaccine 2013; 31:3090-7; PMID:23632305; http://dx.doi.org/10.1016/j.vaccine.2013.03.060
   PubMed Web of Science ®Google Scholar
• Pichichero ME. Booster vaccinations: can immunologic memory outpace disease pathogenesis? Pediatrics 2009; 124:1633-41; PMID:19933727; http://dx.doi.org/10.1542/peds.2008-3645
   PubMed Web of Science ®Google Scholar
• Casal J, Tarrago D. Immunity to Streptococcus pneumoniae: factors affecting production and efficacy. Curr Opin Infect Dis 2003; 16:219-24; PMID:12821811; http://dx.doi.org/10.1097/00001432-200306000-00006
   PubMed Web of Science ®Google Scholar
• Adamou JE, Heinrichs JH, Erwin AL, Walsh W, Gayle T, Dormitzer M, Dagan R, Brewah YA, Barren P, Lathigra R, et al. Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect Immun 2001; 69:949-58; PMID:11159990; http://dx.doi.org/10.1128/IAI.69.2.949-958.2001
   PubMed Web of Science ®Google Scholar
• Garcia P, Gonzalez MP, Garcia E, Lopez R, Garcia JL. LytB, a novel pneumococcal murein hydrolase essential for cell separation. Mol Microbiol 1999; 31:1275-81; PMID:10096093; http://dx.doi.org/10.1046/j.1365-2958.1999.01238.x
   PubMed Web of Science ®Google Scholar
• Glover DT, Hollingshead SK, Briles DE. Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis. Infect Immun 2008; 76:2767-76; PMID:18391008; http://dx.doi.org/10.1128/IAI.01126-07
   PubMed Web of Science ®Google Scholar
• Hava DL, Camilli A. Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol 2002; 45:1389-406; PMID:12207705
   PubMed Web of Science ®Google Scholar
• Marriott HM, Mitchell TJ, Dockrell DH. Pneumolysin: a double-edged sword during the host-pathogen interaction. Curr Mol Med 2008; 8:497-509; PMID:18781957; http://dx.doi.org/10.2174/156652408785747924
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Casey JR, Almudevar A. Reducing the frequency of acute otitis media by individualized care. Pediat Infect Dis J 2013; 32:473-8; PMID:23340550; http://dx.doi.org/10.1097/INF.0b013e3182862b57
   PubMed Web of Science ®Google Scholar
• Aprile MA, Wardlaw AC. Aluminium compounds as adjuvants for vaccines and toxoids in man: a review. Can J Public Health 1966; 57:343-60; PMID:5329166
   PubMed Web of Science ®Google Scholar
• Alho OP, Laara E, Oja H. What is the natural history of recurrent acute otitis media in infancy? J Family Practice 1996; 43:258-64; PMID:8797753
   PubMed Web of Science ®Google Scholar
• Poehling KA, Szilagyi PG, Grijalva CG, Martin SW, LaFleur B, Mitchel E, Barth RD, Nuorti JP, Griffin MR. Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics 2007; 119:707-15; PMID:17403841; http://dx.doi.org/10.1542/peds.2006-2138
   PubMed Web of Science ®Google Scholar
• Sharma SK, Pichichero ME. Cellular immune response in young children accounts for recurrent acute otitis media. Curr Allergy Asthma Rep 2013; 13:495-500; PMID:24022464
   PubMed Web of Science ®Google Scholar
• Pichichero ME. New combination vaccines. Pediat Clin N Am 2000; 47:407-26; PMID:10761511; http://dx.doi.org/10.1016/S0031-3955(05)70214-5
   PubMed Web of Science ®Google Scholar
• Darrieux M, Goulart C, Briles D, Leite LC. Current status and perspectives on protein-based pneumococcal vaccines. Crit Rev Microbiol 2013; PMID:23895377
   PubMed Web of Science ®Google Scholar
• Leroux-Roels G, Maes C, De Boever F, Traskine M, Ruggeberg JU, Borys D. Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical study. Vaccine 2014; 32:6838-46; PMID:24607003; http://dx.doi.org/10.1016/j.vaccine.2014.02.052
   PubMed Web of Science ®Google Scholar
• Bologa M, Kamtchoua T, Hopfer R, Sheng X, Hicks B, Bixler G, Hou V, Pehlic V, Yuan T, Gurunathan S. Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine. Vaccine 2012; 30:7461-8; PMID:23123106; http://dx.doi.org/10.1016/j.vaccine.2012.10.076
   PubMed Web of Science ®Google Scholar
• Simell B, Korkeila M, Pursiainen H, Kilpi TM, Kayhty H. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children. J Infect Dis 2001; 183:887-96; PMID:11237805; http://dx.doi.org/10.1086/319246
   PubMedGoogle Scholar
• Briles DE, Hollingshead SK, Paton JC, Ades EW, Novak L, van Ginkel FW, Benjamin WH Jr. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J Infect Dis 2003; 188:339-48; PMID:12870114; http://dx.doi.org/10.1086/376571
   PubMed Web of Science ®Google Scholar
• Baril L, Briles DE, Crozier P, King JD, Hollingshead SK, Murphy TF, McCormick JB. Natural materno-fetal transfer of antibodies to PspA and to PsaA. Clin Exp Immunol 2004; 135:474-7; PMID:15008981; http://dx.doi.org/10.1111/j.1365-2249.2003.02357.x
   PubMedGoogle Scholar
• Hammerschmidt S, Wolff S, Hocke A, Rosseau S, Muller E, Rohde M. Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. Infect Immun 2005; 73:4653-67; PMID:16040978; http://dx.doi.org/10.1128/IAI.73.8.4653-4667.2005
   PubMed Web of Science ®Google Scholar
• Schulz C, Hammerschmidt S. Exploitation of physiology and metabolomics to identify pneumococcal vaccine candidates. Expert Rev Vaccines 2013; 12:1061-75; PMID:24053399; http://dx.doi.org/10.1586/14760584.2013.824708
   PubMed Web of Science ®Google Scholar
• Verhoeven D, Xu Q, Pichichero ME. Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model. Vaccine 2014; 32:3205-10; PMID:24731814; http://dx.doi.org/10.1016/j.vaccine.2014.04.004
   PubMed Web of Science ®Google Scholar
• Del Giudice G, Rappuoli R. Genetically derived toxoids for use as vaccines and adjuvants. Vaccine 1999; 17 Suppl 2:S44-52; PMID:10506408; http://dx.doi.org/10.1016/S0264-410X(99)00234-0
   PubMedGoogle Scholar